Skip to main content
Blog

Science 37 Forecast—The Adoption of Hybrid Oncology Trials Will Accelerate in 2023 and Beyond

Oncology is a therapeutic area of singular importance in clinical research. Breakthroughs in drug discovery will catalyze numerous studies for targeted cancer treatments, with Evaluate Pharma forecasting that the number of oncology clinical trials could exceed 10,000 by 2026.